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Introduction
Recurrent miscarriage (RM) is defined as the occurrence 
of  3 consecutive first trimester pregnancy losses. It 
affects 1% of  all women (1). The ratio increases from 1% 
to 5%, if  it is defined as ≥2 losses (2). It is a frustrating 
condition both for the couple and the clinician. Among 
women with RM, recurrencerisk appears to be higher 
in those with prior fetal death in contrast to early first 
trimester losses (3). Historically, RM has been attributed 
to chromosomal abnormalities, throm bophilic, 
endocrinologic, immunologic, microbiologic, 
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metabolic, anatomic or iatrogenic factors. Maternal age 
and obesity at conception have both been shown to be 
associated with RM (4,5). However, a great proportion 
of  the causes remain un-explained, despite detailed in-
vestigation (6). 
In approximately 4% of  couples with RM, one of  
the partners carries either a balanced reciprocal 
translocation, in which there is an exchange of  two 
terminal segments from different chromosomes, or, a 
Robertsonian translocation, in which there is a centric 
fusion of  two acrocentric chromosomes (7,8).
Pregnancy is a hypercoaguable state (9,10) and 
thrombophilic disorders are a diverse group of  
coagulation disorders associated with a predisposition 
for thrombotic events. Three common thrombophilic 
mutations were identified: Factor V Leiden (FVL) 
G1691A; factor II prothrombin (PTm) G20210A and 
methylene tetrahydrofolate reductase (MTHFR) C677T. 
There are conflicting studies in the literature about the 
role of  these thrombophilic mutations in RM, and 
results of  some of  thesis were in favor of  the possible 
association between  RM and thrombophilic mutations 
(11,12).
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Abstract
Background: Recurrent miscarriage (RM) is a frequent obstetric problem. Its’ pathophysiology is poorly understood. 
Infections, genetic, endocrine, anatomic and immunologic problems have been suggested as causes for RM. 
Objective: To evaluate the frequency of  chromosomal abnormalities and 3 common thrombophilic mutations in couples 
with RM.
Methods: A retrospective data collection was performed for the results of  the cytogenetic analysis of  the couples and 
Methylenetetrahydrofolate Reductase (MTHFR) C677T, Factor V Leiden (FVL) G1691A and Prothrombin (PTm) G20210A 
mutations of  the mother in 142 couples suffering from RM.  
Results: Prevalence of  FVL, MTHFR, and PTm gene mutations were similar between cases shaving 2 or ≥3 abortions 
(P=0.528; P=0.233; P=0.375). In patients with FVL, MTHFR and PTm gene mutations, the OR’s of  having ≥3 abortions 
when compared to having 2 abortions were 1.515 (95% CI: 0.414-5.552), 0.573 (95% CI: 0.228-1.441), and 2.848 (95% CI: 
0.355-22.871). All cases with PTm mutation had ≥3 abortions and all abortions occurred between 6-8 gestational weeks. 
Conclusion: Chromosomal abnormalities and thrombophilic mutations (especially PTm) seem to have an important role in 
RM. Additional larger studies involving investigation of  more genes that may have a role in pregnancy are needed to assess 
this association. 
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In this study, we wanted to evaluate the frequency of  
chromosomal abnormalities and these 3 common 
thrombophilic mutations in couples with RM.
Methods
This retrospective study was carried out by the Obstetrics 
& Gynecology and Medical Genetics Departments of  
Duzce University School of  Medicine. The study was 
approved by Non-Invasive Human Research Ethics 
Committee of  Duzce University. 178 couples suffering 
from RM (≥2 pregnancy losses that occurred before 
the 20th gestational week) and admitted to the obstetrics 
and gynecology outpatient clinic, between January 
2010 and August 2012 were retrospectively evaluated. 
Demographic characteristics, results of  the maternal 
and paternal chromosomal analysis as well as the results 
of  FVL G1691A; PTm G20210A and MTHFR C677T 
polymorphisms in the mother were obtained from 
patients’ files.  Patients with incomplete records were 
excluded. Patients were evaluated in two groups as those 
having 2 abortions and those having ≥3 abortions.
Cytogenetic Analysis
Metaphase chromosome preparations from the 
peripheral blood cultures were made according to 
standard cytogenetic protocols. Cytogenetic analysis was 
performed by G-bands by trypsin using Giemsa (GTG) 
banding at approximately 400-450 band level. For each 
cases, 20 metaphases were analyzed. Chromosomal 
abnormalities were detected according to the present 
international standard nomenclature (ISCN). 
Isolation of  Genomic DNA
Blood samples were collected in tubes containing 
ethylene diamine tetra acetic acid (EDTA) for DNA 
isolation. Genomic DNA was isolated from individuals 
via fenol-chloroform extraction methods.
Determination of  MTHFR C677T, Factor V Leiden G1691A 
and Factor II Prothrombin G20210A polymorphisms
Polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP) by using appropriate 
primers was used to detect these single nucleotide 
polymorphisms. MTHFR C677T polymorphism was 
detected by using the previously described couples 
of  primers and PCR products were digested by 
Hinf  I restriction endonuclease enzyme (13). FVL 
polymorphism was detected with by using to primers 
FV1, FV2 and the restriction enzyme Mnl 1(14). PTm 
was detected by using 2 primers, PT1 and PT2 followed 
by digestion of  the product with the restriction enzyme 
Hind III (15).
Statistical Analysis 
All analyses were performed using the Statistical 
Package for Social Sciences (SPSS version 15.0) and the 
data were given as mean ± SD and percentages. Pearson 
χ2 and Mann–Whitney U tests were used. The odds 
ratios (OR’s) with 95% confidence intervals (CI’s) were 
calculated. The statistical significance level was defined 
as P < 0.05.
Results
A total of  142 couples were included in the study. Mean 
age of  the women was 30.3±5.5 years (20 - 44), and 
32 of  them were ≥ 35 years. Mean age of  the men 
was 33.1±5.5 years (23 - 46). Parity, abortion and the 
number of  living children were similar in patients < 
and ≥35 years of  age (p=0.167; p=0.358; p=0.153, 
respectively).
Chromosomal analysis of  the couples revealed 128 
normal results, 9 polymorphisms, 3 translocations and 
2 trisomy X for women; 123 normal results and 19 
polymorphisms for men (Table 1).  
Table 1.Chromosom analysis results of  women and men with recurrent miscarriage.
Chromosomal analysis results of  
women
n Chromosomal analysis results of  
men
n
46,XX,1qh+ 5 46,XY,1qh+ 4
47,XXX 2 46,XYqh- 2
46,XX,16qh+ 3 46,XYqh+ 5
46,XX,13pstk+ps+ 1 46,XY,15ps+ 1
46,XX,t(13;16) (q34,q12) 3 46,XY,9qh+ 4
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95% of  the abortions were in the first trimester and 5% 
of  them were in the second trimester. When results of  
the chromosomal analysis were investigated according 
to the number of  abortions; there were 23 normal 
results and 1 polymorphism in couples with 2 abortions; 
84 normal results, 8 polymorphisms, 2 trisomy X and 
2 translocations in couples with 3 abortions and 21 
normal results and 1 translocation in couples with >3 
abortions.  
FVL status was normal, showed a heterozygous mutation 
and showed a homozygous mutation in 118, 19 and 5 of  
the cases, respectively. MTHFR results were normal in 
63 cases, and there was a heterozygous or homozygous 
mutation in 67 and 12 of  the cases, respectively. The 
analysis for PTm were normal in 128 cases and showed 
a heterozygous mutation in 14 cases. Distribution of  the 
FVL, MTHFR, and PTm results of  women according 
to the number of  abortions were shown in table 2 
(p=0.560; p=0.266; p=0.558, respectively).







Normal 118 (83%) 21 (87.5%) 80 (83.3%) 17 (77.2%)
0.560Heterozygotes 19 
(13.3%)
3 (12.5%) 13 (13.5%) 3 (13.6%)








14 (58.3%) 43 (44.8%) 10 (40.1%)
Homozygotes 12 (8.4%) 2 (8.4%) 6 (6.2%) 4 (18.2 %)
PTm Normal 128 
(90.1%)
23 (95.8%) 85 (88.5%) 20 (90.9%)
0.558
Heterozygotes 14 (9.9 %) 1 (4.2%) 11 (11.5%) 2 (9.1%)
FVL: Factor V leiden, MTHFR: Methylenetetrahydrofolate Reductase, PTm:FactorII 
Prothrombin
When mutant allels (homozygotes and heterozygotes) 
were taken into consideration, the prevalence of  
FVL, MTHFR, and PTm gene mutations were similar 
between the cases having 2 and ≥3 abortions (P=0.528; 
P=0.233; P=0.375). In patients with FVL, MTHFR and 
PTm gene mutations, the OR’s of  having ≥3 abortions 
when compared to having 2 abortions were 1.515 (95% 
CI: 0.414-5.552), 0.573 (95% CI: 0.228-1.441), and 
2.848 (95% CI: 0.355-2.871) (Table 3). 
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(n:118) P OR 95% CI
FVL Negative 21 (87.5%) 97 (82.2%) 0.528 1.515 0.414-5.552
Positive 3 (12.5%) 21 (17.8%)
MTHFR Negative 8 (33.3%) 55 (46.6%) 0.233 0.573 0.228-1.441
Positive 16 (66.7%) 63 (53.4%)
PTm Negative 23 (95.8%) 105 (89%) 0.375 2.848 0.355-2.871
Positive 1 (4.2%) 13 (11%)
FVL: Factor V leiden, MTHFR: Methylenetetrahydrofolate Reductase, PTm:Factor II Prthrombin
OR: Odds Ratio CI: Confidence Interval
                    218
The prevalence of  combined mutations of  FVL 
+ MTHFR, FVL + PTm, MTHFR + PTm and 
combination of  3 mutations in patients with 2 and with 
≥3 abortions were similar (P=0.634; P=0.189; P=0.259; 
P=0.430, respectively) (Table 4). 
Table4. Evaluation of  two and three thrombophilic factor combinations (FVL, MTHFR, and PTm gene) in cases 






(n:118) P OR 95% CI
FVL+ MTHFR Negative 21 (87.5%) 107 (90.7%) 0.634 0.720 0.185-2.803
Positive 3 (12.5%) 11 (9.3%)
FVL+ PTm Negative 24 (100%) 110 (93.2%) 0.189 - -
Positive 0 8 (6.8%)
MTHFR+PTm Negative 24 (100%) 112 (94.9%) 0.259 - -
Positive 0 6 (5.1%)
Two factor positive Negative 21 (87.5%) 99 (83.9%) 0.657 1.343 0.364-4.957
Positive 3 (12.5%) 19 (16.1%)
Three factors 
positive
Negative 24 (100%) 115 (97.5%) 0.430 - -
Positive 0 3 (2.5%)
FVL: Factor V leiden, MTHFR: Methylenetetrahydrofolate Reductase, PTm:FactorII 
Prothrombin
OR: Odds Ratio, CI: Confidence Interval
Chromosomal abnormalities and thrombophilic 
mutations (especially PTm) seem to have an important 
role in RM.
Discussion
The rate of  karyotypically abnormal abortion specimens 
increases with maternal age, affected mainly by the 
increase in the rate of  trisomy (16). Chromosomal 
abnormalities are detected in about one-third of  RM’s 
(17). It was reported that normal polymorphic variants 
contribute to chromosomal instability during meiosis 
with a tendency towards an increased risk of  aneuploidy 
which can cause RM or sub-fertility (18). Aberrations 
in the heterochromatin region of  the Y chromosome 
were identified as the most frequent polymorphism in 
infertile men (19). The long (Yqh+) and short (Yqh-) 
chromosome were reported in chromosomal studies 
of  human. (20). While Verp et al. (21) reported Yqh+ 
to be related with an increased risk of  miscarriage, De 
Braekeleer et al. (20) did not report a relation between Y 
chromosome size and increased risk of  pregnancy loss. 
In the present study, there were 14 chromosomal 
abnormalities in women (8 polymorphism, 3 
translocations, 2 trisomy X in women <35 years, and 
only 1 polymorphism ≥ 35 years of  age). In addition to 
this, there were 19 polymorphisms in men, and the rest 
were normal. Five were long (Yqh+) and 2 were short 
(Yqh-) polymorphisms (Table 1). Therefore Yqh+ and/
or Yqh- may be related with an increased risk of  RM.
Thrombophilias make individuals prone to 
thromboembolism and pregnancy complications 
including pregnancy loss. Although the mechanism 
is poorly understood, mutations in genes related with 
coagulation pathways may cause damage to chorionic 
vasculature, decreased trophoblast invasion, apoptosis, 
and impaired uteroplacental circulation due to 
placental thrombosis. The most common hereditary 
thrombophilia is the FVL gene mutation followed 
by the PTm mutation. Both are autosomal dominant 
conditions (22). In a meta-analysis, Rey et al. (12) had 
reported FVL mutation to be associated with early 
and late RM’s and with late non-recurrent fetal loss. 
Some researchers found that there were no significant 
associations between RM and genetic thrombophilias 
(23, 24), others indicated that there may be a possible 
relationship between FVL polymorphism and late 
pregnancy loss (25). In our study, majority of  women 
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(64.1%), suffering from RM had at least one of  the 
3 genetic thrombophilias including FVL, MTHFR or 
PTm polymorphism.
It was reported that heterozygous carriers for the 
PTm allele have a 2 to 8 fold increased risk for venous 
thrombosis (26). Homozygosity for this mutation has 
been described in very few cases (27). A significant 
association between PTm carrier-ship and recurrent 
abortion before 13 weeks of  pregnancy was found (12). 
Similar to the literature findings, in our study, while 128 
of  cases had normal genotype, the others (14 cases) were 
heterozygous carriers for the PTm (Table 2). There was 
no homozygosity for this mutation. 
Some researchers indicated that individuals carrying 
both FVL and PTm mutation have a 20-fold increased 
risk for venous thrombosis. This rate is higher than for 
heterozygous carriers of  PTm or FVL alone. Thus DNA 
analysis of  both mutations is highly recommended in 
cases with a personal or family history of  thrombosis 
(28, 29). It was reported that a meaningful association 
between RM and PTm and FVL polymorphisms (12, 
22, 30). 
In the current study, there were 8 cases carrying both an 
FVL and a PTm mutation. All of  them were heterozygous 
for PTm; 7 of  them were heterozygous carriers for 
FVL, while the other case was a homozygous carrier 
for FVL (only 1 case had 4 abortions, others had 3). 
Although the differences were not meaningful for PTm 
and FVL analysis results of  women, the abortion rate 
increased with the positivity for PTm (OR: 2.848 and 
95% CI: 0.355-22.871) and FVL (OR: 1.515 and 95% 
CI: 0.414-5.552) as shown in table 3. This insignificant 
relation may be due to the small sample size.
It was reported that, although the association of  
pregnancy loss with certain thrombophilic states (such 
as antiphospholipid antibody syndromes, antithrombin 
III deficiency) is clear, its association with inherited 
thrombotic defects such as MTHFR C677T and FVL 
polymorphisms are slightly disputable (24). In fact, an 
estimated 10% of  all clinical pregnancies are lost in the 
first and early second trimester (31), fewer than 3% of  
pregnancies are lost later in gestation. The recurrence 
risk for pregnancy loss appears to be higher in those with 
previous fetal death in contrast to early first trimester 
losses in women with RM (3). According to our findings, 
a great number of  abortions (95%) were observed in 
first trimester, and (5%) in second trimester. 
While a lot of  studies showed the association of  
MTHFR C677T polymorphism and increased risk for 
RM (32-35), some studies reported a lack of  relation 
between this polymorphism and RM (24, 36, 37). In this 
study, MTHFR gene mutations were associated with a 
0.573 (95% CI: 0.228-1.441) fold risk of   having ≥3 
abortions when compared to having 2 abortions (Table 
3).
The prevalence of  FVL + MTHFR, FVL + PTm, 
MTHFR + PTm and combination of  three mutations 
were similar in patients with 2 and with ≥3 abortions 
(Table 4). Interestingly, in the situations which included 
PTm mutation, all cases had≥3 abortions and all 
abortions occurred between 6-8th gestational weeks 
(Table 4). Therefore the presence of  PTm gene mutation 
may be important and may cause early pregnancy losses. 
Therefore, evaluation of  the PTm gene mutation in 
patients with RM may important.   
Conclusion 
Chromosomal abnormalities and abnormalities in the 
genes related to thrombophilia such as FVL, MTHFR 
and PTm mutations may be considered as risk factors 
for RM. Detection of  these factors may be important 
to begin early and appropriate treatment for couples 
suffering from RM. Thus the physical, psychological 
discomfort for couples and financial loss for both 
of  couples and governments might be decreased the 
minimum levels. Additional studies including many 
genes which have functionally significant variant alleles 
in pregnancy and a large case series should be performed 
to obtain more information about this issue.
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